Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Lyell Immunopharma, Inc. (LYEL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2023"
06/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/04/2023 8-K Quarterly results
02/28/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022"
12/16/2022 8-K Quarterly results
11/08/2022 8-K Quarterly results
10/24/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
08/04/2022 8-K Quarterly results
Docs: "Lyell Immunopharma Reports Second Quarter Financial Results and Business Highlights"
06/13/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/29/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Lyell Immunopharma Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights"
02/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/17/2021 8-K Quarterly results
12/02/2021 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
11/12/2021 8-K Quarterly results
Docs: "Lyell Immunopharma Reports Third Quarter 2021 Financial Results and Business Highlights ● Cash and investments of $936.4 million as of September 30, 2021 supports advancing multi-modality cell therapy pipeline"
10/01/2021 8-K/A Quarterly results
09/30/2021 8-K Quarterly results
08/12/2021 8-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy